Intellectual Property

  • June 18, 2026

    Senate Panel Advances Revised College Sports Reform Bill

    The U.S. Senate Commerce Committee approved a bill to codify federal protections for college sports and for athletes' earning abilities, sending it to the full Senate for a possible vote.

  • June 18, 2026

    News Orgs Must Give Cohere AI Use Policies

    A New York federal magistrate judge has ordered a group of news and magazine publishers to turn over their policies on how artificial intelligence is used in their newsrooms to AI startup Cohere, as Cohere stands accused of improperly using copyrighted news content to train chatbots.

  • June 18, 2026

    Bill For AI Deepfake Reporting System Clears Senate Panel

    A bill that would create a pathway for reporting AI-generated deepfakes online for removal cleared the Senate Judiciary Committee on Thursday after a few senators had raised concerns over First Amendment implications but said they believed they could be resolved before a full Senate vote.

  • June 18, 2026

    Starbucks Sues To Block Union From Using Name And Logo

    Starbucks sued Starbucks Workers United on Thursday in Iowa federal court, seeking to block the group from using the company brand and countering a suit the union filed in April.

  • June 18, 2026

    Patent Claims On Novartis Unit Drug Invalid, Del. Judge Says

    A Delaware federal judge has cleared radiopharmaceutical companies of allegations they infringed claims in various patents owned by a French unit of Novartis after finding that all of those claims were invalid.

  • June 17, 2026

    Eve Legal Accused By AI.Law Of Infringing AI Drafting Tech

    Eve Legal ripped off legal tech company AI.Law's patent that allows lawyers and other legal professionals to use artificial intelligence to generate legal documents, AI.Law alleged in a patent infringement lawsuit filed Wednesday in California federal court.

  • June 17, 2026

    Eli Lilly Urges Full Fed. Circ. To Scrap Teva's $177M IP Win

    Eli Lilly & Co. urged the full Federal Circuit Wednesday to review a panel ruling that upheld Teva's $177 million jury verdict on headache drug patents, arguing that the panel's decision runs afoul of the justices' Amgen holding and "opens a truck-sized hole in enablement and written description law."

  • June 17, 2026

    Acer Can't Nix Texas Jury's $10M Verdict Over Monitor Patents

    A Texas federal judge rejected Acer's effort to wipe out a jury's $10.3 million infringement award to rival SVV Technology Innovations over optical-film patents for monitors, finding the jury's verdict was supported by the evidence and the company's criticism of an SVV expert's methodology is too late.

  • June 17, 2026

    Hikma Ruling Raises Patent Pleading Bar Beyond Drug Cases

    The U.S. Supreme Court's decision this month that shut down a patent suit against Hikma Pharmaceuticals USA over a drug using a so-called skinny label could also make it more challenging to plead induced infringement in cases involving other technologies, attorneys say.

  • June 17, 2026

    Sen. Committee Clears Drug Disclosure, Biosimilar Bills

    The U.S. Senate Committee on Health, Education, Labor and Pensions on Wednesday cleared two bills for full Senate review, tackling the gap between health and patent oversight agencies, and the need for more interchangeable biosimilars.

  • June 17, 2026

    ITC, Masimo Tell Full Fed. Circ. To Skip Apple Watch Review

    Masimo Corp. and the U.S. International Trade Commission have pushed back on Apple's request for full Federal Circuit rehearing of a panel decision finding an older version of the Apple Watch infringes Masimo's patents, saying Wednesday the case isn't exceptional enough for such scrutiny.

  • June 17, 2026

    Amazon Urges Fed. Circ. To Halt Patent Suit In Texas

    Amazon has asked the Federal Circuit to force a Texas federal court to pause a suit accusing it of infringing a pair of Headwater Research LLC patents while a similar suit against Google plays out.

  • June 17, 2026

    Del. Court Invalidates Patent Claims In Bioscience Co. Row

    A federal magistrate judge in Delaware on Wednesday found that claims in three molecular labeling patents held by Parse Biosciences Inc. were invalid, months after he found that they weren't infringed by Scale Biosciences Inc.

  • June 17, 2026

    Fed. Circ. Affirms No Block On Stryker Spine Device In IP Fight

    The Federal Circuit on Wednesday agreed with a lower court decision rejecting Boston Scientific Corp.'s request to temporarily block Stryker Corp. from launching a back pain device, saying Stryker made a good enough case that it didn't cause physicians to infringe a patent on the treatment.

  • June 17, 2026

    Adobe Faces Derivative Claims For AI Copyright Infringement

    Executives and directors of Adobe have been hit with a derivative suit from investors accusing them of exposing the software giant to financial and reputational harm by concealing that the company used copyrighted material to create artificial intelligence tools.

  • June 17, 2026

    Nasdaq Private Market Says Rival Poached Staff And Secrets

    A Nasdaq marketplace for pre-IPO stock has filed suit against a competitor, alleging that it has poached employees and clients, stolen trade secrets and other confidential information, and infringed its patented technology in an effort to acquire what Nasdaq has built without fairly competing.

  • June 17, 2026

    Sanctioned IP Atty Tells Fed. Circ. 'Integrity' On The Line

    An attorney who was sanctioned in a trade dress infringement case due to what a judge said were his repeated misrepresentations has asked the Federal Circuit to lift the penalties against him and his client, saying his "professional and personal integrity, and my family, depends on it."

  • June 17, 2026

    Meta Trims But Can't Toss Eminem Publishers' $109M IP Suit

    A Michigan federal judge has found Eminem's music publishers can proceed with claims accusing Meta of unlawfully putting hundreds of the rapper's songs in Facebook, Instagram and WhatsApp music libraries, but dismissed their claims that the technology giant should be liable for users sharing or reusing the songs.

  • June 17, 2026

    Justices Asked To Review 'Headscratching' Copyright Ruling

    A group of major music publishers has asked the U.S. Supreme Court to rein in a "headscratching" Fifth Circuit ruling that the music publishers say transformed U.S. copyright termination rights into a worldwide reset button for ownership of foreign copyrights.

  • June 17, 2026

    Sunoco Tells High Court It Was Denied Fair Patent Damages

    Sunoco wants the U.S. Supreme Court to hear its argument that it was shortchanged when it won "a mere $12 million" in a gasoline blending patent suit against Magellan Midstream, saying it wasn't given the opportunity to show that it actually lost more than 12 times that amount.

  • June 17, 2026

    Pickleball Paddle Maker Settles With Rival In ITC Patent Probe

    A pickleball paddle maker has reached a settlement with one of the companies it targeted at the U.S. International Trade Commission with claims of infringing a patent, removing the rival from the probe.

  • June 16, 2026

    Midjourney Faces Discovery Limits Into Studios' AI Use

    A California federal magistrate judge Monday ordered Disney, Universal and Warner Bros. to produce some data on their own use of artificial intelligence in the studios' copyright lawsuit against Midjourney, finding that some requested information is appropriate, but Midjourney's broader requests are irrelevant or shielded under work product privileges.

  • June 16, 2026

    FIFA Mural Suit, Other Fights Showcase 'Obscure' Art Law

    As soccer heavyweights and underdogs square off in the FIFA World Cup, the sport's worldwide governing body is staring down a suit claiming the organization destroyed a mural and violated a unique intellectual property protection that has a history of thwarting the removal of public pieces of art.

  • June 16, 2026

    THC Drink Co. Hid Auto-Renewal Fee, Calif. Suit Claims

    The maker of cannabis-infused beverage Brez intentionally concealed automatic renewal terms on its website in "small" gray font in order to charge an online shopper a recurring $54.21 subscription fee, according to a Los Angeles County lawsuit, which will be getting a new judge, according to a Monday order.

  • June 16, 2026

    Eli Lilly Settles Mounjaro TM Suit Against Seattle Area Clinics

    Eli Lilly has agreed to drop a lawsuit accusing two Washington clinics of ripping off its trademarks for the weight loss drugs Mounjaro and Zepbound, according to a voluntary dismissal motion filed in federal court on Monday, almost two weeks after a judge rejected a resolution proposed by the parties. 

Expert Analysis

  • Examining Privilege In Dual-Purpose Workplace Investigations

    Author Photo

    The Sixth Circuit's recent holding in FirstEnergy's bribery probe ruling that attorney-client privilege applied to a dual-purpose workplace investigation because its primary purpose was obtaining legal advice highlights the uncertainty companies face as federal circuit courts remain split on the appropriate test, say attorneys at Proskauer.

  • Opinion

    The Case For Emulating, Not Dividing, The Ninth Circuit

    Author Photo

    Champions for improved judicial administration should reject the unfounded criticisms driving recent Senate proposals to divide the Ninth Circuit and instead seek to replicate the court's unique strengths and successes, says Ninth Circuit Judge J. Clifford Wallace.

  • Why 'Baby Shark' Floundered In Foreign Service Waters

    Author Photo

    The Second Circuit recently ruled that the "Baby Shark" company couldn’t use email to serve alleged infringers based in China under an international agreement prohibiting such service, providing several important lessons for parties in actions involving defendants in jurisdictions unwilling or unable to effectuate efficient service, say attorneys at Greenspoon Marder.

  • How Chinese Utility Models Fit Into Global IP Strategies

    Author Photo

    Recent guidelines from the China National Intellectual Property Administration put the spotlight on the value of Chinese utility models — especially for device-focused innovations — and the interplay between utility models and conventional Chinese patents, say attorneys at Foley & Lardner.

  • Series

    Muay Thai Makes Me A Better Lawyer

    Author Photo

    Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.

  • Higher Expectations For 'Schedule A' IP Suits On The Horizon

    Author Photo

    Two 2025 rulings may reflect a growing judicial discomfort with the current state of Schedule A litigation — intellectual property lawsuits that typically involve brand owners suing multiple defendants doing business on e-commerce platforms — and that evidentiary submissions and temporary restraining order requests may face more rigorous review, says Dylan Scher at Quinn Emanuel.

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • Trending At The PTAB: The Policies That Are Redefining IPR

    Author Photo

    The evolution of the Patent Trial and Appeal Board's inter partes review institution regime last year, coupled with the policy considerations behind that evolution, marks a shift toward greater gatekeeping of the U.S. Patent and Trademark Office's resources and patent enforcement rights, say attorneys at Finnegan.

  • Reviewing 2025's Artificial Intelligence Disputes Over IP

    Author Photo

    2025 brought the first major fair use rulings involving generative artificial intelligence, and in 2026 courts will weigh in on more discovery disputes, renewed motions to dismiss, class certification challenges and fair use defenses that could shape the course of future AI litigation, say attorneys at Debevoise.

  • Trending At The PTAB: The Journey Of IPR Institution In 2025

    Author Photo

    Over the course of 2025, inter partes review institution at the Patent Trial and Appeal Board evolved into a more restrictive, policy-driven regime with reshaped discretionary briefing and assessment, and increasing procedural requirements, say attorneys at Finnegan.

  • 4 Developments That Defined The 2025 Ethics Landscape

    Author Photo

    The legal profession spent 2025 at the edge of its ethical comfort zone as courts, firms and regulators confronted how fast-moving technologies and new business models collide with long-standing professional duties, signaling that the profession is entering a period of sustained disruption that will continue into 2026, says Hilary Gerzhoy at HWG Law.

  • 5 Trade Secret Developments To Follow In 2026

    Author Photo

    Watch for major developments in trade secret law this year, especially as courts clarify the reach of U.S. law internationally, the availability of trade secret damages and more, say attorneys at Faegre Drinker.

  • Navigating AI In The Legal Industry

    Author Photo

    As artificial intelligence becomes an increasingly integral part of legal practice, Law360 guest commentary this year examined evolving ethical obligations, how the plaintiffs bar is using AI to level the playing field against corporate defense teams, and the attendant risks of adoption.

  • Opinion

    Judges Carry Onus To Screen Expert Opinions Before Juries

    Author Photo

    Recent Second Circuit arguments in Acetaminophen Products Liability Litigation implied a low bar for judicial gatekeeping of expert testimony, but under amended Rule 702 of the Federal Rules of Evidence, judges must rigorously scrutinize expert opinions before allowing them to reach juries, says Lee Mickus at Evans Fears.

  • Labubu Highlights Evolving IP Strategies In Modern Markets

    Author Photo

    Pop Mart's decision not to pursue U.S. patents for its Labubu plush dolls — relying instead on expressive rights — is rational given the nature of the product and the velocity of the market, and also underscores broader structural issues that may hold the U.S. patent system from keeping pace with modern markets, says Tina Dorr at Barnes & Thornburg.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.